SILVER SPRING, Md., April 12, 2018 /PRNewswire-USNewswire/ — The U.S. Food and Drug Administration today finalized two guidances to drive the efficient development of a novel technology that scans a person’s DNA to diagnose genetic diseases, which are usually hereditary, and guide…
